Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.96
-0.22 (-1.97%)
May 19, 2026, 1:15 PM HKT

HKG:2096 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
28,85231,07117,65317,61130,91423,628
Market Cap Growth
32.48%76.01%0.24%-43.03%30.83%1.20%
Enterprise Value
26,19929,48515,63916,20529,37123,209
Last Close Price
11.1811.976.986.4210.848.23
PE Ratio
18.6020.7722.9822.3729.3812.77
Forward PE
12.4816.5814.3512.1129.0426.63
PS Ratio
3.353.612.502.424.323.85
PB Ratio
2.752.972.332.213.832.98
P/TBV Ratio
3.313.572.782.514.163.10
P/FCF Ratio
15.5816.7816.25-27.04-
P/OCF Ratio
12.8813.8711.92105.8320.19-
PEG Ratio
-1.121.121.121.121.12
EV/Sales Ratio
3.053.432.222.234.113.78
EV/EBITDA Ratio
13.1015.4110.6215.9031.8644.76
EV/EBIT Ratio
16.6318.7013.0720.6942.8581.03
EV/FCF Ratio
14.1515.9214.39-25.69-
Debt / Equity Ratio
0.130.130.170.200.210.25
Debt / EBITDA Ratio
0.660.660.831.431.723.50
Debt / FCF Ratio
0.710.711.18-1.49-
Net Debt / Equity Ratio
-0.25-0.25-0.11-0.08-0.16-0.08
Net Debt / EBITDA Ratio
-1.39-1.39-0.54-0.64-1.37-1.30
Net Debt / FCF Ratio
-1.44-1.44-0.741.77-1.101.33
Asset Turnover
0.590.590.590.610.600.47
Inventory Turnover
2.092.091.802.844.013.59
Quick Ratio
1.951.951.731.761.691.51
Current Ratio
2.212.212.012.101.841.63
Return on Equity (ROE)
16.24%16.24%10.06%9.94%13.62%25.41%
Return on Assets (ROA)
6.73%6.73%6.26%4.11%3.62%1.38%
Return on Invested Capital (ROIC)
17.91%18.77%15.42%10.83%10.15%4.14%
Return on Capital Employed (ROCE)
12.50%12.50%12.70%8.70%7.80%3.30%
Earnings Yield
5.18%4.81%4.35%4.47%3.40%7.83%
FCF Yield
6.42%5.96%6.16%-2.08%3.70%-2.14%
Dividend Yield
1.82%1.67%2.44%2.74%1.67%2.24%
Payout Ratio
29.07%29.07%55.61%58.65%42.04%25.96%
Buyback Yield / Dilution
1.25%1.25%3.40%0.45%-0.34%-9.14%
Total Shareholder Return
3.07%2.92%5.83%3.19%1.32%-6.91%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.